Prognostic Value and Correlation Between WT1 Overexpression and NPM1 Mutation in Patients with Acute Myeloblastic Leukemia

Background. Acute myeloblastic leukemia (AML) with NPM1 mutation amounts to 30 % of all AML and is characterized by good prognosis with the exception of cases with FLT3-ITD mutation. Despite the good prognosis, the likelihood of relapses in patients with NPM1 mutation may significantly differ. Thus,...

Descrizione completa

Dettagli Bibliografici

Autori principali:	L. L. Girshova, Irina Garmaevna Budaeva, E. G. Ovsyannikova, S. O. Kuzin, D. V. Motorin, R. Sh. Badaev, D. B. Zammoeva, V. V. Ivanov, K. V. Bogdanov, O. S. Pisotskaya, Yu. V. Mirolyubova, T. S. Nikulina, Yu. A. Alekseeva, A. Yu. Zaritskii
Natura:	Artigo
Lingua:	Russo
Pubblicazione:	Practical Medicine Publishing House 2017-10-01
Serie:	Клиническая онкогематология
Soggetti:	acute myeloblastic leukemia aml npm1 wt1 molecular monitoring
Accesso online:	https://bloodjournal.ru/index.php/coh/article/view/455
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!